Page last updated: 2024-10-30

metformin and Addiction, Opioid

metformin has been researched along with Addiction, Opioid in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
" Thus, in the current study, we aimed to investigate the effects of metformin on the development of morphine and/or methadone-induced tolerance in human glioblastoma (T98G) cell line."3.91In vitro evaluation of effects of metformin on morphine and methadone tolerance through mammalian target of rapamycin signaling pathway. ( Dehpour, AR; Esmaeili, J; Sahebgharani, M; Shirooie, S, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barengolts, E1
Green, SJ1
Eisenberg, Y1
Akbar, A1
Reddivari, B1
Layden, BT1
Dugas, L1
Chlipala, G1
Shirooie, S1
Sahebgharani, M1
Esmaeili, J1
Dehpour, AR1

Trials

1 trial available for metformin and Addiction, Opioid

ArticleYear
Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease.
    PloS one, 2018, Volume: 13, Issue:3

    Topics: Bacteria; Black or African American; Chronic Disease; Cost of Illness; Cross-Sectional Studies; Diab

2018

Other Studies

1 other study available for metformin and Addiction, Opioid

ArticleYear
In vitro evaluation of effects of metformin on morphine and methadone tolerance through mammalian target of rapamycin signaling pathway.
    Journal of cellular physiology, 2019, Volume: 234, Issue:3

    Topics: AMP-Activated Protein Kinase Kinases; Analgesics, Opioid; Animals; Cell Line, Tumor; Cyclic AMP; Dru

2019